Cardica Inc.
900 Saginaw Drive
Redwood City,
CA 94063
United States - Map
Phone: 650-364-9975
Fax: 650-364-3134
Web Site: http://www.cardica.com
| Cardica, Inc. designs, manufactures, and markets proprietary automated anastomotic systems used by surgeons to perform coronary artery bypass surgery. The companys products include C-Port Distal Anastomosis System, which is designed to perform an end-to-side distal anastomosis by attaching the end of a bypass graft to a coronary artery downstream of an occlusion or narrowing; C-Port Flex A Anastomosis System that includes modifications to the C-Port xA system designed to enable automated anastomoses to be performed as part of minimally invasive and robot-facilitated CABG procedures; and C-Port X-CHANGE system, a cartridge-based reloadable C-Port system. Its products also comprise PAS-Port Proximal Anastomosis System, an automated device used to perform an end-to-side proximal anastomosis between a saphenous vein and the aorta. In addition, the company develops the Cook Vascular Closure Device to be used in interventional vascular procedures; and Cardica Microcutter, an endoscopic microcutter intended for use by general, thoracic, gynecologic, bariatric, and urologic surgeons. Cardica primarily sells the C-Port systems in the United States and Europe, and the PAS-Port systems in the United States, Europe, and Japan through distributors. It has a collaboration agreement with Cook Incorporated to develop Patent Foramen Ovale Closure Device that is designed to close holes in the heart from genetic heart defects known as patent foramen ovales. The company was formerly known as Vascular Innovations, Inc. and changed its name to Cardica, Inc. in November 2001. The company was founded in 1997 and is based in Redwood City, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Bernard A. Hausen M.D., Ph.D., 49
Co-Founder, Chief Exec. Officer, Pres, Chief Medical Officer |
N/A
| N/A | Mr. Robert Y. Newell IV, 60
Chief Financial Officer, Principal Accounting Officer, VP of Fin. and Sec. |
N/A
| N/A | Dr. Bryan D. Knodel Ph.D, 49
VP of R&D |
N/A
| N/A | Mr. Frederick M. Bauer , 55
VP of Operations |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
2.03% Nasdaq 
Profile
